Gene Edited Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gene-edited neurons use precise genome editing technologies to introduce, correct, or modulate specific genetic modifications for studying neurodegenerative disease mechanisms and developing therapies.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
- Cas9 nucleases
- Base editors
- Prime editors
- Cas variants
- TALENs
- ZFNs
- Meganucleases
- Homology-directed repair
- Disease mutations
- Reporter genes
- Conditional alleles
- Tag insertions
- Gene removal
- Exon deletion
- Frameshift mutations
- Conditional knockout
- Expression调控
- Splicing modification
- Regulatory changes
- Epigenetic editing
- APP gene editing
- Tau gene modifications
- APOE allele swaps
- Risk factor genes
- SNCA mutations
- LRRK2 corrections
- GBA1 modifications
- Mitochondrial genes
- ALS gene corrections
- Huntington's targeting
- Prion disease models
- Polyglutamine disorders
- Patient iPSC editing
- Autologous transplantation
- Gene-corrected cells
- Immune-matched neurons
- Direct brain delivery
- AAV vectors
- Viral approaches
- Non-viral methods
- Off-target effects
- Immunogenicity
- Delivery specificity
- Long-term expression
- Germline editing
- Informed consent
- Equitable access
- Regulatory pathways
- Patient-specific mutations
- Corrected controls
- Multiple backgrounds
- Reporter integrations
- Mechanism investigation
- Drug target validation
- Phenotypic screening
- Pathway analysis
The study of Gene Edited Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Doudna & Charpentier, CRISPR-Cas9 (2014)
- Kantor & McCown, Gene editing in neurons (2020)
- Hernández et al., CRISPR for PD (2020)
- Koch & Ehmueller, Gene therapy for neurodegeneration (2021)